{ "benchmark_id": "36382181_01", "sample_system": "", "tissue": "Prostate", "source_type": "cell_line", "perturbation_type": "drug", "perturbation_name": "enzalutamide", "default_cell_subset": "", "description": "LNCaP prostate cancer cells treated with 5 uM enzalutamide over 4, 7, and 14 days.", "smiles": "CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C", "test_cases": [ { "test_id": "36382181_01_01", "target_genes": [ "ENO2", "STEAP2" ], "perturb_var": "dose", "control": "C", "dose_groups": [ "5.0 uM" ], "time_groups": [ "14 day" ], "relation": "UP", "cell_type": "LNCaP prostate cancer cell line" }, { "test_id": "36382181_01_02", "target_genes": [ "KLK2", "KLK3", "FKBP5" ], "perturb_var": "dose", "control": "C", "dose_groups": [ "5.0 uM" ], "time_groups": [ "14 day" ], "relation": "DOWN", "cell_type": "LNCaP prostate cancer cell line" }, { "test_id": "36382181_01_03", "target_genes": [ "AR" ], "perturb_var": "dose", "control": "C", "dose_groups": [ "5.0 uM" ], "time_groups": [ "14 day" ], "relation": "UP", "cell_type": "LNCaP prostate cancer cell line" }, { "test_id": "36382181_01_04", "target_genes": [ "ENO2", "ENO2", "STEAP2" ], "perturb_var": "dose", "control": "C", "dose_groups": [ "5.0 uM" ], "time_groups": [ "14 day" ], "relation": "UP", "cell_type": "LNCaP prostate cancer cell line" }, { "test_id": "36382181_01_07", "target_genes": [ "ASCL1", "NCAM1", "SYP" ], "perturb_var": "dose", "control": "C", "dose_groups": [ "5.0 uM" ], "time_groups": [ "14 day" ], "relation": "NS", "cell_type": "LNCaP prostate cancer cell line" }, { "test_id": "36382181_01_05", "target_genes": [ "KLK2", "KLK3", "FKBP5" ], "perturb_var": "dose", "control": "C", "dose_groups": [ "5.0 uM" ], "time_groups": [ "14 day" ], "relation": "DOWN", "cell_type": "LNCaP prostate cancer cell line" }, { "test_id": "36382181_01_06", "target_genes": [ "AR" ], "perturb_var": "dose", "control": "C", "dose_groups": [ "5.0 uM" ], "time_groups": [ "14 day" ], "relation": "UP", "cell_type": "LNCaP prostate cancer cell line" } ] }